1. Kaplan-Meier survival curve demonstrating treatment duration of metformin and orlistat.
Kaplan-Meier survival curve demonstrating treatment duration of metformin and orlistat. Figure shows proportion still actively prescribed antiobesity drug for orlistat and metformin by time since initiation, beginning from time 0 (100% active prescriptions) out to 85 months (longer active prescription).
Billy White et al. bmjpo 2017;1:e000104
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) All rights reserved. No commercial use is permitted unless otherwise expressly granted.